About
Gene On Biotech develops QUAI, an AI-quantum drug discovery platform powered by proteome-scale experimental data. Using a 20,000-human-protein microarray, QUAI accelerates peptide therapeutic design through quantum-enhanced computational methods. The platform combines quantum computing with artificial intelligence for pharmaceutical research and drug development. Exhibited at CES 2025.
Quantum Specifications
| Quantum Focus | hardware |
Backed By
Lakestar
Lightspeed Venture Partners
Quantum Coast Capital
Type One Ventures
Trumpf Venture
Gic Government Of Singapore Investment Corporation
Hercules Capital
Inven Capital
Application Areas
Drug discoveryPeptide therapeutics
Frequently Asked Questions
Gene On Biotech develops QUAI, an AI-quantum drug discovery platform powered by proteome-scale experimental data. Using a 20,000-human-protein microarray, QUAI accelerates peptide therapeutic design through quantum-enhanced computational methods. The platform combines quantum computing with artificial intelligence for pharmaceutical research and drug development. Exhibited at CES 2025.
Gene On Biotech is headquartered in Seoul, South Korea.
Gene On Biotech was founded in 2019.
Gene On Biotech operates in the following sectors: quantum software, quantum machine learning, quantum pharma, quantum simulation, quantum algorithms.